Supreme Court Rules That FDA Drug Approval Can’t Prevent Defective Drug Lawsuits

On March 5, the Supreme Court made a decision that should help those seeking to sue drug companies over defective drugs or medical products. With a 6-3 ruling, the court ruled that the approval of a drug by the Food and Drug Administration (FDA) cannot prevent a patient from bringing a defective drug lawsuit to court against the drug company in question.

Experts believe that this ruling will make drug companies increase safety measures in relation to their product, since they could still be held accountable if their defective medical products hurt consumers. Drug testing and drug research could increase outside of FDA testing, while some more experimental drug development could be halted. At the same time, other drugs already on the market could be pulled off shelves because pharmaceutical companies are anticipating future lawsuits that they will not be immune to.

If you believe you have been injured or harmed by a defective drug, it is vital that you contact an experienced defective drug injury attorney immediately.